CD24 and carcinoma: Accumulated evidences demonstrated that CD24 belonged to the glycosylphosphatidylinositol-anchored membrane protein, and the targeting CD24 therapeutic strategies have been positively verified in many human carcinomas by inhibiting tumor proliferation and metastasis [33].